Protection against malaria at 1 year and immune correlates following PfSPZ vaccination
暂无分享,去创建一个
Mario Roederer | Sumana Chakravarty | Martha C Nason | Andrea A. Berry | S. Hoffman | S. Kappe | G. Fahle | M. Roederer | B. Graham | J. Ledgerwood | J. Todd | B. Sack | C. Plowe | Srinivas S. Rao | K. Lyke | R. Seder | P. Billingsley | T. Richie | L. Garver | M. E. Enama | N. Björkström | A. DeZure | A. Eappen | S. Chakravarty | B. Flynn | M. Nason | J. Epstein | M. Laurens | A. Gunasekera | E. James | A. Ruben | Lee-Jah Chang | Kathryn L. Zephir | U. Sarwar | I. Gordon | L. Holman | Anita Manoj | Minglin Li | Tao Li | R. Stafford | S. Plummer | C. S. Hendel | L. Novik | P. Costner | Floreliz H. Mendoza | J. Saunders | S. Davidson | A. Ishizuka | Natasha K C | Tooba Murshedkar | H. Decederfelt | W. Whalen | Jay Noor | K. Sierra-Davidson | G. Lynn | M. Kemp | S. Mikolajczak | Matthew E. Fishbaugher | B. K. Sim | Thomas L Richie | Brandon K Sack | Tao Li | Anusha Gunasekera | Stefan H I Kappe | Christopher V Plowe | Tooba Murshedkar | Adam J Ruben | Anita Manoj | Peter F Billingsley | Eric R James | Stephen L Hoffman | Abraham G Eappen | Lee-Jah Chang | Ingelise J. Gordon | MingLin Li | Sarah H. Plummer | Laura Novik | Kirsten E Lyke | Andrew S Ishizuka | Andrea A Berry | Adam DeZure | Mary E Enama | Richard E Stafford | Floreliz H Mendoza | Ingelise J Gordon | Kathryn L Zephir | LaSonji A Holman | Sarah H Plummer | Cynthia S Hendel | Pamela J M Costner | Jamie G Saunders | Matthew B Laurens | Barney S Graham | Julie E Ledgerwood | Robert A Seder | Judith E Epstein | Niklas K Björkström | B Kim Lee Sim | Srinivas Rao | Matthew Fishbaugher | Kailan Sierra-Davidson | Uzma N Sarwar | Natasha K C | Hope DeCederfelt | Barbara Flynn | William R Whalen | J P Todd | Jay Noor | Geoffrey M Lynn | Margaret A Kemp | Gary A Fahle | Sebastian A Mikolajczak | Silas A Davidson | Lindsey S Garver | A. Berry | C. NatashaK | Pamela J. Costner | M. Enama
[1] W. Jiskoot,et al. Vaccines , 2013, Reactions Weekly.
[2] Lloyd H. Michael,et al. The Guide for the Care and Use of Laboratory Animals. , 2016, ILAR journal.
[3] S. Hoffman,et al. The march toward malaria vaccines. , 2015, Vaccine.
[4] Peter G. Kremsner,et al. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. , 2015 .
[5] Jay B. Varkey,et al. Human Ebola virus infection results in substantial immune activation , 2015, Proceedings of the National Academy of Sciences.
[6] Andrea J. Radtke,et al. The chemokine receptor CXCR6 is required for the maintenance of liver memory CD8⁺ T cells specific for infectious pathogens. , 2014, The Journal of infectious diseases.
[7] A. Vaughan,et al. Model for In Vivo Assessment of Humoral Protection against Malaria Sporozoite Challenge by Passive Transfer of Monoclonal Antibodies and Immune Serum , 2013, Infection and Immunity.
[8] Mario Roederer,et al. Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine , 2013, Science.
[9] Andrea J. Radtke,et al. In vivo imaging of CD8+ T cell-mediated elimination of malaria liver stages , 2013, Proceedings of the National Academy of Sciences.
[10] A. Vaughan,et al. Quantitative Bioluminescent Imaging of Pre-Erythrocytic Malaria Parasite Infection Using Luciferase-Expressing Plasmodium yoelii , 2013, PloS one.
[11] A. Scott,et al. Unique transcriptional profile of liver-resident memory CD8+ T cells induced by immunization with malaria sporozoites , 2013, Genes and Immunity.
[12] Zheng W. Chen. Multifunctional immune responses of HMBPP-specific Vγ2Vδ2 T cells in M. tuberculosis and other infections , 2012, Cellular and Molecular Immunology.
[13] G. van Gemert,et al. Reduced Plasmodium berghei sporozoite liver load associates with low protective efficacy after intradermal immunization , 2012, Parasite immunology.
[14] A. Vaughan,et al. A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle. , 2012, Molecular and biochemical parasitology.
[15] Yasushi Kawakami,et al. Enhancement of dendritic cell activation via CD40 ligand-expressing γδ T cells is responsible for protective immunity to Plasmodium parasites , 2012, Proceedings of the National Academy of Sciences.
[16] Udo Albus,et al. Guide for the Care and Use of Laboratory Animals (8th edn) , 2012 .
[17] W. Weiss,et al. Protective CD8+ T lymphocytes in Primates Immunized with Malaria Sporozoites , 2012, PloS one.
[18] R. Sauerwein,et al. Longevity and Composition of Cellular Immune Responses Following Experimental Plasmodium falciparum Malaria Infection in Humans , 2011, PLoS pathogens.
[19] E. R. James,et al. Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity , 2011, Science.
[20] R. Sauerwein,et al. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study , 2011, The Lancet.
[21] Mario Roederer,et al. SPICE: Exploration and analysis of post‐cytometric complex multivariate datasets , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[22] Prashant Yadav,et al. A Research Agenda for Malaria Eradication: Vaccines , 2011, PLoS medicine.
[23] S. Hoffman,et al. Plasmodium falciparum Malaria Challenge by the Bite of Aseptic Anopheles stephensi Mosquitoes: Results of a Randomized Infectivity Trial , 2010, PloS one.
[24] J. Harty,et al. Extreme CD8 T Cell Requirements for Anti-Malarial Liver-Stage Immunity following Immunization with Radiation Attenuated Sporozoites , 2010, PLoS pathogens.
[25] Sumana Chakravarty,et al. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria , 2010, Human vaccines.
[26] E. Alexandre,et al. Isolation and culture of primary hepatocytes from resected human liver tissue. , 2010, Methods in molecular biology.
[27] S. Hoffman,et al. The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria. , 2009, The Journal of infectious diseases.
[28] V. A. Stewart,et al. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. , 2009, The Journal of infectious diseases.
[29] R. Tampé,et al. Cross-presenting human γδ T cells induce robust CD8+ αβ T cell responses , 2009, Proceedings of the National Academy of Sciences.
[30] M. D'Ombrain,et al. Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] Garrett Fitzmaurice,et al. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort , 2008, The Lancet.
[32] Hong Wang,et al. Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vγ2Vδ2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens , 2007, Immunological reviews.
[33] R. Koup,et al. Intracellular cytokine optimization and standard operating procedure , 2006, Nature Protocols.
[34] M. Carta,et al. An open label follow-up study on amisulpride in the add-on treatment of bipolar I patients , 2006, Clinical practice and epidemiology in mental health : CP & EMH.
[35] S. Shorte,et al. Quantitative imaging of Plasmodium transmission from mosquito to mammal , 2006, Nature Medicine.
[36] B. Moser,et al. Professional Antigen-Presentation Function by Human γδ T Cells , 2005, Science.
[37] Patricia De la Vega,et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. , 2002, The Journal of infectious diseases.
[38] S. Plotkin. Immunologic correlates of protection induced by vaccination , 2001, The Pediatric infectious disease journal.
[39] S. Hoffman,et al. The Complexity of Protective Immunity Against Liver-Stage Malaria1 2 , 2000, The Journal of Immunology.
[40] S. Tonegawa,et al. Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[41] S. Hoffman,et al. A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei. , 1992, Journal of immunology.
[42] S. Hoffman,et al. Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. , 1991, Science.
[43] S. Hoffman,et al. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites. , 1991, Journal of immunology.
[44] S. Hoffman,et al. Plasmodium falciparum-infected Anopheles stephensi inconsistently transmit malaria to humans. , 1990, The American journal of tropical medicine and hygiene.
[45] S. Hoffman,et al. Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. , 1989, Science.
[46] M. Good,et al. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[47] V. Nussenzweig,et al. γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites , 1987, Nature.
[48] S. Hoffman,et al. Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum. , 1986, The American journal of tropical medicine and hygiene.
[49] V. Nussenzweig,et al. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection , 1980, The Journal of experimental medicine.
[50] L. Kramer,et al. Intramuscular immunization of mice with irradiated Plasmodium berghei sporozoites. Enhancement of protection with albumin. , 1975, The American journal of tropical medicine and hygiene.